Improving Access to CVD Medicines in Brazil

Partnership objective

Improve access to medicines used in the thrombolytic therapy of acute myocardial infarction and stroke.

The program aims to improve access to medicines used in the thrombolytic therapy of acute myocardial infarction and stroke. The program aims to improve access to medicines used in the thrombolytic therapy of acute myocardial infarction and stroke. Copyright Photo Credits: Boehringer Ingelheim

Description of partnership activities and how they address needs and challenges

Boehringer Ingelheim Brazil developed a common agenda with the Ministry of Health to add medicines used in the thrombolytic therapy of acute myocardial infarction and stroke to the reimbursement list, improving access for the patients by offering a significant discount for those products.

Partnership information

Company(ies) Boehringer Ingelheim

Partner(s) Brazilian Ministry of Health

Type of Partner(s) Government

Therapeutic Focus Non-Communicable Diseases

Disease(s) Cardiovascular Diseases

Program Type(s) Availability of Treatment - Differential Pricing

Targeted Population(s) General population

Region(s) Latin America & Caribbean

Number of Countries 1

Country(ies) Brazil

Start Date 2012

More information For Better Health Brochure

Anticipated completion date Ongoing